证券研究报告·海外公司点评·食物饮品(HS) 中烟香港（06055.HK） 境内免税市场独家出口卷烟，毛利率有望提 升 买入（维持） | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万港元） | 11,836 | 13,074 | 14,856 | 16,071 | 17,470 | | 同比(%) | 42.19 | 10.46 | 13.63 | 8.17 | 8.71 | | 归母净利润（百万港元） | 598.77 | 853.74 | 938.26 | 1,057.95 | 1,300.22 | | 同比(%) | 59.71 | 42.58 | 9.90 | 12.76 | 22.90 | | EPS-最新摊薄（港元/股） | 0.87 | 1.23 | 1.36 | 1.53 | 1.88 | | P/E（现价&最新摊薄） | 52.81 | 37.04 | 33.70 | 29.89 | 24.32 | [Table_Ta ...

Core Viewpoint - China Tobacco Hong Kong (06055) has signed significant tobacco sales framework agreements, indicating strong future business growth confidence and potential expansion into new markets [1] Group 1: Stock Performance - China Tobacco Hong Kong's stock rose over 4%, specifically 4.23%, reaching HKD 42.36, with a trading volume of HKD 47.4351 million [1] Group 2: Agreements and Financial Projections - The company signed a framework agreement with Leaf Trading, setting annual transaction limits for 2026, 2027, and 2028 at HKD 6.7 million, HKD 8.4 million, and HKD 9.8 million respectively [1] - A framework agreement with China Tobacco International (North America) was established for the export of tobacco leaf products to new regions, with increased annual transaction limits for 2026 and 2027 set at HKD 466 million and HKD 490 million, reflecting increases of 538.4% and 456.8% respectively [1] Group 3: Strategic Implications - The significant adjustment in transaction limits demonstrates the company's confidence in future business growth [1] - The procurement agreements are expected to enhance the export of tobacco leaf products to Southeast Asia, diversify customer structures, and attract more potential buyers from broader regions [1] - The company aims to secure high-quality raw material supplies, gradually expanding beyond exclusive sales regions, thereby increasing its growth potential [1]

Core Viewpoint - The company has entered into a framework agreement with Leaf Trading for the sale of tobacco leaf products, which is expected to enhance its business development and meet global market demand for these products [1] Group 1: Agreement Details - The agreement with Leaf Trading is set to commence on January 27, 2026, focusing on the sale of tobacco leaf products [1] - The company anticipates that other contacts globally, such as Pyxus, will also procure tobacco leaf products for their production needs or for resale to end customers [1] Group 2: Business Development - The framework agreement is seen as a significant step towards further business development for the company [1] - The company aims to generate additional revenue by satisfying overseas demand for tobacco leaf products, aligning with its business and commercial objectives [1]

Core Viewpoint - The company has entered into a framework agreement with Leaf Trading for the sale of tobacco leaf products, which is expected to enhance its business development and meet global market demand for these products [1] Group 1: Agreement Details - The agreement with Leaf Trading is set to commence on January 27, 2026, focusing on the sale of tobacco leaf products [1] - The company anticipates that other contacts globally, such as Pyxus, will also procure tobacco leaf products for their production needs or for resale to end customers [1] Group 2: Business Development - The framework agreement is seen as a significant step towards further business development for the company [1] - The company aims to generate additional revenue by satisfying overseas demand for tobacco leaf products, aligning with its business and commercial objectives [1]

Core Viewpoint - The company has entered into a framework agreement with Leaf Trading for the sale of tobacco leaf products, which is expected to enhance its business development and meet global market demand for these products [1]. Group 1: Agreement Details - The company announced a framework agreement with Leaf Trading for the sale of tobacco leaf products, effective January 27, 2026 [1]. - This agreement is part of the company's strategy to expand its sales and export business in tobacco leaf products [1]. Group 2: Business Relationships - The company has established a long-term and stable export business relationship with Alliance One Group for tobacco leaf product sales [1]. - The company anticipates that other global contacts, such as Pyxus and Leaf Trading, will also procure tobacco leaf products for their production needs or for resale to end customers worldwide [1]. Group 3: Future Business Development - The company believes that the agreement with Leaf Trading will contribute to further business development by meeting overseas demand for tobacco leaf products, thereby generating additional revenue [1]. - This initiative aligns with the company's business and commercial objectives, marking an important step in its growth strategy [1].

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [13][14]. Core Insights - The company is the only publicly listed entity within the China Tobacco system, tasked with the mission of "international business expansion and capital market operations" [9][18]. - The company has a unique business model with stable operations and strong profit margins, benefiting from exclusive rights in its operations [10][31]. - The company has significant potential for both organic growth and external acquisitions, with a vast reserve of overseas assets within the China Tobacco system [9][10]. Summary by Sections Business Overview - The company operates as the core platform for overseas capital operations and international business expansion within the China Tobacco system [9][18]. - It is expected to integrate high-quality overseas assets from the China Tobacco system and actively seek external acquisition targets to enhance its growth [9][10]. Financial Performance - From 2016 to 2024, the company's revenue and net profit are projected to grow at CAGRs of 10% and 12%, respectively, indicating a stable upward trend in operations [9][10]. - The company has a light asset model with high return on equity (ROE), primarily relying on inventory and receivables, with fixed assets valued at less than 100 million HKD [10][35]. Tobacco Leaf Business - The company has exclusive rights to import and export tobacco leaves, with a projected CAGR of 11% for its import business from 2018 to 2024 [57]. - The pricing model for imported tobacco leaves is based on a fixed markup, typically around 6% [57]. Cigarette Export Business - The company operates in duty-free shops across two countries (Thailand and Singapore) and has a dual model of self-operated and wholesale sales, covering over 200 duty-free outlets [10][31]. - The long-term growth of the cigarette export business is expected to be driven by an increase in self-operated sales, product category expansion, and growth in taxable channels [10][31]. Global Development - The company is positioned to benefit from the global trend towards new tobacco products, with ongoing efforts to expand its market presence in Southeast Asia, Eastern Europe, and the Middle East [12][31]. - The company has already seen significant growth in its Brazilian operations, with revenue increasing from 315 million HKD in 2021 to 1.05 billion HKD in 2024, reflecting a CAGR of 49.4% [11][12]. New Tobacco Products - The company is actively developing its new tobacco product export business, focusing on heated non-combustible products, with plans to expand into various international markets [12][31]. - The long-term outlook for this segment is positive, contingent on the introduction of competitive new tobacco products by local industrial companies [12][31].

Core Viewpoint - China Tobacco Hong Kong (06055) saw a significant increase in stock price, rising over 6% to HKD 46.7, with a trading volume of HKD 223 million, indicating positive market sentiment towards the company [1] Group 1: Business Performance - The three core business segments of China Tobacco Hong Kong contribute significantly to its revenue, with the import of tobacco leaf products accounting for 81.4%, export of tobacco leaf products for 11.2%, and cigarette exports for 5.3%, totaling 98.0% of revenue [1] - The gross profit contributions from these segments are 72.6% from tobacco leaf imports, 6.7% from tobacco leaf exports, and 15.0% from cigarette exports, aggregating to 94.3% of gross profit [1] Group 2: Market Developments - Guotai Junan Securities highlighted that British American Tobacco recently announced the launch of its glo series in Italy and Poland, including new products glo Hilo, glo HiloPlus, and virto heated tobacco sticks, following a positive market response in Japan [1] - The performance of Hilo in key European markets will be closely monitored for its sales impact [1] Group 3: Future Outlook - CITIC Securities anticipates steady growth in revenue and profit for China Tobacco Hong Kong in the first half of 2025, driven by robust growth in tobacco leaf import and export businesses, along with a decrease in financial expenses [1] - The company aims to maintain its strategic positioning as a platform for overseas capital market operations and international business expansion, suggesting potential for leapfrog development [1]

Core Viewpoint - The company, China Tobacco Hong Kong (06055), demonstrates stable performance through optimization of product structure and business model, enhancing profitability while maintaining a steady dividend payout to shareholders. The company is expected to leverage its overseas business integration platform [1]. Group 1: Financial Performance - For the mid-2025 period, the company's revenue reached HKD 10.316 billion, representing a year-on-year growth of 18.5%. The gross profit was HKD 946 million, a decrease of 1.8%, while the net profit attributable to shareholders was HKD 706 million, an increase of 9.8%. The mid-term earnings met expectations [2]. - The company maintained a steady dividend policy, with a mid-term dividend per share of HKD 0.19, reflecting a year-on-year increase of 26.7% [2]. Group 2: Core Business Contributions - The three core business segments—import of tobacco leaf products, export of tobacco leaf products, and cigarette export—contributed 81.4%, 11.2%, and 5.3% to total revenue, respectively, totaling 98.0%. The gross profit contributions were 72.6%, 6.7%, and 15.0%, respectively, totaling 94.3% [3]. - The import business of tobacco leaf products generated revenue of HKD 8.399 billion, a year-on-year increase of 23.5%, with a gross profit of HKD 687 million, down 7.7% due to rising costs from CBT procurement outpacing sales prices [3]. - The export business of tobacco leaf products achieved revenue of HKD 1.156 billion, a year-on-year increase of 25.9%, with a gross profit of HKD 63.1 million, up 124.1%, driven by the expansion into new markets and increased export volume and prices [3]. - The cigarette export business reported revenue of HKD 552 million, a year-on-year increase of 0.8%, with a gross profit of HKD 142 million, up 16.8%, attributed to the expansion of self-operated channels and the introduction of new products [3]. Group 3: Profitability Outlook - The company's gross margin and net profit margin for mid-2025 were 9.2% and 6.8%, respectively. The company continues to optimize its product structure and business model, with improvements in gross margins across most business segments, except for the import of tobacco leaf products, which saw a decline [4].

Core Viewpoint - 中烟香港 (06055) demonstrates stable performance through optimization of product structure and business model, enhancing profitability while maintaining steady dividend growth for shareholders. The company is expected to continue leveraging its overseas business integration platform [1] Financial Performance - For the mid-2025 results, the company reported revenue of 10.316 billion HKD, an 18.5% year-on-year increase; gross profit of 946 million HKD, a 1.8% decrease; and net profit attributable to shareholders of 706 million HKD, a 9.8% year-on-year increase. The mid-term dividend per share is 0.19 HKD, reflecting a 26.7% increase [2] Revenue and Profit Contribution - The three core business segments contribute significantly to revenue and profit: - Tobacco leaf import business: 81.4% of revenue and 72.6% of gross profit - Tobacco leaf export business: 11.2% of revenue and 6.7% of gross profit - Cigarette export business: 5.3% of revenue and 15.0% of gross profit [3] - Tobacco leaf import business revenue reached 8.399 billion HKD, a 23.5% increase, with gross profit of 687 million HKD, a 7.7% decrease due to rising costs outpacing sales prices. - Tobacco leaf export business revenue was 1.156 billion HKD, a 25.9% increase, with gross profit of 63.1 million HKD, a 124.1% increase, driven by market expansion and increased sales volume and prices. - Cigarette export business revenue was 552 million HKD, a 0.8% increase, with gross profit of 142 million HKD, a 16.8% increase, attributed to expanded self-operated channels and new product introductions [3] Profitability Outlook - The company's gross margin and net profit margin for mid-2025 were 9.2% and 6.8%, respectively. The company continues to optimize its product structure and business model, with improvements in gross margins for most business segments, except for the tobacco leaf import business [4]

Core Viewpoint - The company reported strong revenue growth and stable profits for the first half of 2025, driven by the import and export of tobacco leaf products, as well as cigarette exports, while increasing shareholder returns through dividends [1][2][4]. Revenue Summary - The company achieved a revenue of HKD 10.32 billion, representing an 18.5% increase year-on-year [1]. - Tobacco leaf imports generated revenue of HKD 8.40 billion, up 23.5%, with an import volume of 97,900 tons, a 2.5% increase, and an average import price of HKD 8.58 million per ton, up 20.5% [1]. - Tobacco leaf exports saw revenue of HKD 1.16 billion, a 25.9% increase, with an export volume of 38,500 tons, up 12.7%, and an average export price of HKD 30,000 per ton, up 11.7% [2]. - Cigarette exports generated revenue of HKD 550 million, a slight increase of 0.8%, with an export volume of 1.019 billion sticks, down 7.9%, and an average export price of HKD 0.54 per stick, up 9.4% [2]. Profitability Summary - The net profit for the first half of 2025 was HKD 706 million, reflecting a 9.8% increase, with a gross margin of 9.2%, down 1.9 percentage points [1]. - The gross margin for tobacco leaf imports was 8.2%, down 2.8 percentage points, primarily due to increased costs from CBT-sourced tobacco exceeding sales price increases [1]. - The gross margin for tobacco leaf exports improved to 5.5%, up 2.4 percentage points, due to enhanced pricing strategies and market expansion efforts [2]. - The gross margin for cigarette exports increased to 25.7%, up 3.5 percentage points, despite a decline in export volume [2]. Dividend and Future Outlook - The company proposed an interim dividend of HKD 0.19 per share, representing a 27% increase [1]. - The profit forecast for 2025-2027 has been raised, with expected net profits of HKD 940 million, HKD 1.04 billion, and HKD 1.18 billion, reflecting year-on-year growth of 9.6%, 11.4%, and 12.9% respectively [4]. - The diluted EPS is projected to be HKD 1.35, HKD 1.51, and HKD 1.70 for the years 2025, 2026, and 2027, with corresponding PE ratios of 27, 25, and 22 [4].